

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.72964350 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.66509338 |
| 3 | sodium ion export (GO:0071436) | 4.15725741 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.10657802 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.07751616 |
| 6 | cellular potassium ion homeostasis (GO:0030007) | 4.05896420 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 3.87628865 |
| 8 | protein localization to endosome (GO:0036010) | 3.80289645 |
| 9 | glutamate secretion (GO:0014047) | 3.69419364 |
| 10 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.66994551 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.63964892 |
| 12 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.63106534 |
| 13 | response to peptidoglycan (GO:0032494) | 3.59430447 |
| 14 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.51862223 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.50278165 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.49814770 |
| 17 | neuromuscular process controlling posture (GO:0050884) | 3.48312534 |
| 18 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.46699447 |
| 19 | proline transport (GO:0015824) | 3.43666046 |
| 20 | neurotransmitter secretion (GO:0007269) | 3.38156540 |
| 21 | glycine transport (GO:0015816) | 3.30192779 |
| 22 | cell communication by electrical coupling (GO:0010644) | 3.29852333 |
| 23 | alanine transport (GO:0032328) | 3.27088138 |
| 24 | regulation of early endosome to late endosome transport (GO:2000641) | 3.26905556 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24777723 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 3.22557072 |
| 27 | vocalization behavior (GO:0071625) | 3.16401616 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.15622811 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.14734856 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 3.14665455 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14212919 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.14212919 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14212919 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14212919 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14212919 |
| 36 | modulation by symbiont of host immune response (GO:0052553) | 3.14212919 |
| 37 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.12436123 |
| 38 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.09212130 |
| 39 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.06696039 |
| 40 | neuronal action potential propagation (GO:0019227) | 3.05843283 |
| 41 | cellular sodium ion homeostasis (GO:0006883) | 3.04426028 |
| 42 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.99379044 |
| 43 | barbed-end actin filament capping (GO:0051016) | 2.98810034 |
| 44 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98470849 |
| 45 | exploration behavior (GO:0035640) | 2.96674330 |
| 46 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.93462704 |
| 47 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.93410363 |
| 48 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91491022 |
| 49 | regulation of synapse structural plasticity (GO:0051823) | 2.88218608 |
| 50 | activation of protein kinase A activity (GO:0034199) | 2.85539082 |
| 51 | mannose metabolic process (GO:0006013) | 2.84592327 |
| 52 | protein localization to synapse (GO:0035418) | 2.83918898 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 2.82008998 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.81772321 |
| 55 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.79928203 |
| 56 | activation of MAPKKK activity (GO:0000185) | 2.79849955 |
| 57 | modulation by symbiont of host cellular process (GO:0044068) | 2.79807546 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 2.79135328 |
| 59 | stress fiber assembly (GO:0043149) | 2.78007325 |
| 60 | synaptic vesicle endocytosis (GO:0048488) | 2.77921356 |
| 61 | COPI coating of Golgi vesicle (GO:0048205) | 2.77853602 |
| 62 | Golgi transport vesicle coating (GO:0048200) | 2.77853602 |
| 63 | neuromuscular process controlling balance (GO:0050885) | 2.75144673 |
| 64 | potassium ion import (GO:0010107) | 2.74355120 |
| 65 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.72917722 |
| 66 | protein retention in ER lumen (GO:0006621) | 2.72817483 |
| 67 | glycosphingolipid catabolic process (GO:0046479) | 2.72505553 |
| 68 | neurotransmitter transport (GO:0006836) | 2.71234103 |
| 69 | long-term memory (GO:0007616) | 2.69166079 |
| 70 | detection of molecule of bacterial origin (GO:0032490) | 2.68618402 |
| 71 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.68374619 |
| 72 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.68025931 |
| 73 | adhesion of symbiont to host (GO:0044406) | 2.66316197 |
| 74 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.62750650 |
| 75 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.62361706 |
| 76 | layer formation in cerebral cortex (GO:0021819) | 2.59838627 |
| 77 | glutamate receptor signaling pathway (GO:0007215) | 2.59705856 |
| 78 | potassium ion homeostasis (GO:0055075) | 2.59607834 |
| 79 | membrane depolarization during action potential (GO:0086010) | 2.59144497 |
| 80 | germinal center formation (GO:0002467) | 2.57643187 |
| 81 | positive regulation of vesicle fusion (GO:0031340) | 2.57539846 |
| 82 | synaptic transmission, glutamatergic (GO:0035249) | 2.56798905 |
| 83 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.56749832 |
| 84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.56654643 |
| 85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.56139403 |
| 86 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.55934720 |
| 87 | response to muramyl dipeptide (GO:0032495) | 2.55127958 |
| 88 | regulation of neurotransmitter levels (GO:0001505) | 2.54786983 |
| 89 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.54251496 |
| 90 | positive regulation of receptor recycling (GO:0001921) | 2.53021672 |
| 91 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.52584389 |
| 92 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.52397081 |
| 93 | virion attachment to host cell (GO:0019062) | 2.51534488 |
| 94 | adhesion of symbiont to host cell (GO:0044650) | 2.51534488 |
| 95 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.50482745 |
| 96 | mating behavior (GO:0007617) | 2.48287759 |
| 97 | regulation of ARF protein signal transduction (GO:0032012) | 2.48276340 |
| 98 | positive regulation of synapse maturation (GO:0090129) | 2.47513406 |
| 99 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47491000 |
| 100 | negative regulation of cell killing (GO:0031342) | 2.47491000 |
| 101 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.45857842 |
| 102 | type I interferon signaling pathway (GO:0060337) | 2.45009756 |
| 103 | cellular response to type I interferon (GO:0071357) | 2.45009756 |
| 104 | response to laminar fluid shear stress (GO:0034616) | 2.44683987 |
| 105 | cell migration in hindbrain (GO:0021535) | 2.44507443 |
| 106 | detection of other organism (GO:0098543) | 2.43326489 |
| 107 | response to type I interferon (GO:0034340) | 2.42361793 |
| 108 | regulation of vesicle fusion (GO:0031338) | 2.42012004 |
| 109 | detection of external biotic stimulus (GO:0098581) | 2.41506425 |
| 110 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.40523984 |
| 111 | regulation of synaptic plasticity (GO:0048167) | 2.40395696 |
| 112 | T-helper 1 type immune response (GO:0042088) | 2.39909355 |
| 113 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.39768155 |
| 114 | neuron-neuron synaptic transmission (GO:0007270) | 2.39536132 |
| 115 | regulation of postsynaptic membrane potential (GO:0060078) | 2.38876813 |
| 116 | regulation of cholesterol storage (GO:0010885) | 2.38650765 |
| 117 | regulation of extracellular matrix disassembly (GO:0010715) | 2.38631184 |
| 118 | positive regulation of membrane potential (GO:0045838) | 2.38396384 |
| 119 | regulation of leukocyte degranulation (GO:0043300) | 2.38317367 |
| 120 | glycolipid catabolic process (GO:0019377) | 2.38259320 |
| 121 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.36755124 |
| 122 | positive regulation of type 2 immune response (GO:0002830) | 2.36501256 |
| 123 | regulation of neurotransmitter secretion (GO:0046928) | 2.36453165 |
| 124 | semaphorin-plexin signaling pathway (GO:0071526) | 2.36093536 |
| 125 | detection of bacterium (GO:0016045) | 2.36084524 |
| 126 | response to thyroid hormone (GO:0097066) | 2.35909298 |
| 127 | glucose 6-phosphate metabolic process (GO:0051156) | 2.35598430 |
| 128 | myeloid dendritic cell differentiation (GO:0043011) | 2.35564987 |
| 129 | positive regulation of protein dephosphorylation (GO:0035307) | 2.35410375 |
| 130 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.34388295 |
| 131 | neutrophil activation involved in immune response (GO:0002283) | 2.34301978 |
| 132 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.33923418 |
| 133 | immunoglobulin mediated immune response (GO:0016064) | 2.33698056 |
| 134 | positive regulation of extracellular matrix organization (GO:1903055) | 2.32375910 |
| 135 | cerebellar Purkinje cell layer development (GO:0021680) | 2.32292188 |
| 136 | signal complex assembly (GO:0007172) | 2.31908316 |
| 137 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.31125379 |
| 138 | amyloid precursor protein catabolic process (GO:0042987) | 2.30355139 |
| 139 | neuromuscular process (GO:0050905) | 2.29540922 |
| 140 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.27107998 |
| 141 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.26658250 |
| 142 | prepulse inhibition (GO:0060134) | 2.26652070 |
| 143 | innervation (GO:0060384) | 2.26573660 |
| 144 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.26206145 |
| 145 | amino sugar catabolic process (GO:0046348) | 2.25089464 |
| 146 | cell-cell junction maintenance (GO:0045217) | 2.25022004 |
| 147 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.24325437 |
| 148 | regulation of neurotransmitter transport (GO:0051588) | 2.23416435 |
| 149 | membrane repolarization (GO:0086009) | 2.23383458 |
| 150 | regulation of macrophage cytokine production (GO:0010935) | 2.23028604 |
| 151 | response to auditory stimulus (GO:0010996) | 2.22885698 |
| 152 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.22565129 |
| 153 | positive regulation of fibroblast migration (GO:0010763) | 2.22521129 |
| 154 | regulation of beta-amyloid formation (GO:1902003) | 2.22313814 |
| 155 | dopamine receptor signaling pathway (GO:0007212) | 2.21482240 |
| 156 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.21455034 |
| 157 | membrane depolarization (GO:0051899) | 2.21381320 |
| 158 | dendrite morphogenesis (GO:0048813) | 2.21206313 |
| 159 | modulation by virus of host process (GO:0019054) | 2.21011627 |
| 160 | regulation of type 2 immune response (GO:0002828) | 2.20713513 |
| 161 | pinocytosis (GO:0006907) | 2.20406883 |
| 162 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.20269203 |
| 163 | positive regulation of macrophage cytokine production (GO:0060907) | 2.20255021 |
| 164 | positive regulation of synaptic transmission (GO:0050806) | 2.20248025 |
| 165 | L-amino acid import (GO:0043092) | 2.19164129 |
| 166 | response to manganese ion (GO:0010042) | 2.18665795 |
| 167 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.18449884 |
| 168 | cell communication involved in cardiac conduction (GO:0086065) | 2.18400099 |
| 169 | membrane hyperpolarization (GO:0060081) | 2.18229257 |
| 170 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.16852854 |
| 171 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.16470397 |
| 172 | long-term synaptic potentiation (GO:0060291) | 2.16425677 |
| 173 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.15811245 |
| 174 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.15662634 |
| 175 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.15631838 |
| 176 | basement membrane organization (GO:0071711) | 2.15625621 |
| 177 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.15295812 |
| 178 | positive regulation of sodium ion transport (GO:0010765) | 2.15100684 |
| 179 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.14447442 |
| 180 | regulation of synaptic transmission (GO:0050804) | 2.14413626 |
| 181 | suckling behavior (GO:0001967) | 2.14229948 |
| 182 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.14090490 |
| 183 | activation of Rac GTPase activity (GO:0032863) | 2.14000824 |
| 184 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.13869730 |
| 185 | negative regulation of cell size (GO:0045792) | 2.13519188 |
| 186 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.13505126 |
| 187 | regulation of mast cell degranulation (GO:0043304) | 2.13325101 |
| 188 | negative regulation of protein oligomerization (GO:0032460) | 2.13149667 |
| 189 | low-density lipoprotein particle clearance (GO:0034383) | 2.13147323 |
| 190 | regulation of defense response to virus by virus (GO:0050690) | 2.12906583 |
| 191 | neuron cell-cell adhesion (GO:0007158) | 2.12620357 |
| 192 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.11886780 |
| 193 | regulation of podosome assembly (GO:0071801) | 2.11006264 |
| 194 | apoptotic cell clearance (GO:0043277) | 2.10997410 |
| 195 | regulation of regulated secretory pathway (GO:1903305) | 2.10513193 |
| 196 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.09991312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.26878091 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.94061883 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.82576553 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.48318820 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.46154951 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42832832 |
| 7 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.39642292 |
| 8 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27133677 |
| 9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.26534992 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.23991336 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.22334107 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.16357215 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16354946 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.16116819 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14910599 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.14057445 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.08271839 |
| 18 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.07983544 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.06501690 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02995537 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02995537 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93387818 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.91607619 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88910729 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87570072 |
| 26 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.84887807 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.84808847 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.83606542 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81814619 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80963164 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.79533786 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.78469470 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78339949 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75776440 |
| 35 | * MYC_22102868_ChIP-Seq_BL_Human | 1.75208630 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.70743111 |
| 37 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.70368289 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.67839931 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63284623 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62477968 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62177103 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.60540189 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58477452 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57890645 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.57045415 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51656369 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51031138 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.50715777 |
| 49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.50695646 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.50515216 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49830088 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49364556 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47369340 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46945840 |
| 55 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45429041 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.45289382 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43746708 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40778938 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39814862 |
| 60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38587139 |
| 61 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38207885 |
| 62 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37447310 |
| 63 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37000222 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35665009 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35090975 |
| 66 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34333281 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32725085 |
| 68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30315446 |
| 69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29975456 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29522644 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28930971 |
| 72 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.28901941 |
| 73 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28199290 |
| 74 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.27049430 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26937238 |
| 76 | MAF_26560356_Chip-Seq_TH1_Human | 1.26567183 |
| 77 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26199265 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26000444 |
| 79 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25704735 |
| 80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25694856 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25082109 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23646690 |
| 83 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22954947 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22649137 |
| 85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19871613 |
| 86 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18275289 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17404773 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16257578 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15844492 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14682271 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14577221 |
| 92 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14342898 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12672239 |
| 94 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11878194 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11801673 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11728686 |
| 97 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11480644 |
| 98 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11442545 |
| 99 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.11236399 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10475672 |
| 101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09615475 |
| 102 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07342921 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05540673 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04978937 |
| 105 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04904922 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 1.03067255 |
| 107 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02888466 |
| 108 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02272038 |
| 109 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02129724 |
| 110 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02064097 |
| 111 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01811988 |
| 112 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01051702 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00740380 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99631759 |
| 115 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97968152 |
| 116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97928125 |
| 117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97335174 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96959091 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96642830 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96356754 |
| 121 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95921582 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95829616 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94215834 |
| 124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93715342 |
| 125 | * P68_20966046_ChIP-Seq_HELA_Human | 0.91812805 |
| 126 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.90719844 |
| 127 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90614557 |
| 128 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89896013 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89538336 |
| 130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89206310 |
| 131 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89109476 |
| 132 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.88808437 |
| 133 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.88780610 |
| 134 | AR_19668381_ChIP-Seq_PC3_Human | 0.88399824 |
| 135 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86516711 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.85997254 |
| 137 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85081998 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83897858 |
| 139 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83502967 |
| 140 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.82619473 |
| 141 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.82354837 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82278941 |
| 143 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81861481 |
| 144 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.81543954 |
| 145 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81187575 |
| 146 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80990462 |
| 147 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.80453921 |
| 148 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.79522916 |
| 149 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79075712 |
| 150 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.79057295 |
| 151 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79030424 |
| 152 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.78144480 |
| 153 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77574201 |
| 154 | SA1_27219007_Chip-Seq_Bcells_Human | 0.76296569 |
| 155 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76054300 |
| 156 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75909422 |
| 157 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.75494156 |
| 158 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.75372039 |
| 159 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74898441 |
| 160 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74774492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.33625040 |
| 2 | MP0003303_peritoneal_inflammation | 3.72469058 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.44246429 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.16729639 |
| 5 | MP0005451_abnormal_body_composition | 2.89641842 |
| 6 | MP0003436_decreased_susceptibility_to | 2.84482470 |
| 7 | MP0004858_abnormal_nervous_system | 2.79502741 |
| 8 | MP0004510_myositis | 2.69554066 |
| 9 | MP0002822_catalepsy | 2.66856576 |
| 10 | MP0002064_seizures | 2.60776661 |
| 11 | MP0009046_muscle_twitch | 2.59488566 |
| 12 | MP0009745_abnormal_behavioral_response | 2.53765436 |
| 13 | MP0003329_amyloid_beta_deposits | 2.51620716 |
| 14 | MP0004270_analgesia | 2.51041651 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.49701166 |
| 16 | MP0003880_abnormal_central_pattern | 2.43805936 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.43572583 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.30184235 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.16007128 |
| 20 | MP0003075_altered_response_to | 2.09254145 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.06485395 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.06260211 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.05530991 |
| 24 | MP0008260_abnormal_autophagy | 2.05492729 |
| 25 | MP0006082_CNS_inflammation | 2.04118660 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.92131959 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 1.89280403 |
| 28 | MP0003724_increased_susceptibility_to | 1.88687512 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.87311261 |
| 30 | MP0002272_abnormal_nervous_system | 1.86469868 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.86100999 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.85686021 |
| 33 | MP0002419_abnormal_innate_immunity | 1.84800673 |
| 34 | MP0002736_abnormal_nociception_after | 1.82978502 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.81498576 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.81286724 |
| 37 | MP0009785_altered_susceptibility_to | 1.79193409 |
| 38 | MP0001970_abnormal_pain_threshold | 1.78339415 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.76764293 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.76400177 |
| 41 | MP0004947_skin_inflammation | 1.76175507 |
| 42 | MP0005025_abnormal_response_to | 1.75216828 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.69808110 |
| 44 | MP0008569_lethality_at_weaning | 1.64993684 |
| 45 | MP0003633_abnormal_nervous_system | 1.64126138 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.63971784 |
| 47 | MP0004130_abnormal_muscle_cell | 1.63917505 |
| 48 | MP0000604_amyloidosis | 1.63020693 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.62410577 |
| 50 | MP0001849_ear_inflammation | 1.59872434 |
| 51 | MP0003091_abnormal_cell_migration | 1.57895533 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.57743090 |
| 53 | MP0000858_altered_metastatic_potential | 1.57210390 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.56346620 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.54666994 |
| 56 | MP0000343_altered_response_to | 1.54572476 |
| 57 | MP0001790_abnormal_immune_system | 1.54105046 |
| 58 | MP0005387_immune_system_phenotype | 1.54105046 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.53619970 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.51831822 |
| 61 | MP0005167_abnormal_blood-brain_barrier | 1.50960264 |
| 62 | MP0002067_abnormal_sensory_capabilities | 1.50808650 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.50645613 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.50602915 |
| 65 | MP0000685_abnormal_immune_system | 1.48326406 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 1.47436639 |
| 67 | MP0001486_abnormal_startle_reflex | 1.44397434 |
| 68 | MP0004811_abnormal_neuron_physiology | 1.43131872 |
| 69 | MP0008961_abnormal_basal_metabolism | 1.42247765 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 1.41803796 |
| 71 | MP0002653_abnormal_ependyma_morphology | 1.39530776 |
| 72 | MP0004043_abnormal_pH_regulation | 1.37689768 |
| 73 | MP0003690_abnormal_glial_cell | 1.36971481 |
| 74 | MP0005535_abnormal_body_temperature | 1.35790258 |
| 75 | MP0005360_urolithiasis | 1.34946014 |
| 76 | MP0003879_abnormal_hair_cell | 1.34085730 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.33600834 |
| 78 | MP0003279_aneurysm | 1.33265148 |
| 79 | MP0004233_abnormal_muscle_weight | 1.29474405 |
| 80 | MP0000920_abnormal_myelination | 1.28322636 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 1.27999452 |
| 82 | MP0004885_abnormal_endolymph | 1.24561235 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 1.23760269 |
| 84 | MP0010155_abnormal_intestine_physiology | 1.22059075 |
| 85 | MP0003631_nervous_system_phenotype | 1.21304007 |
| 86 | MP0003448_altered_tumor_morphology | 1.20388895 |
| 87 | MP0010329_abnormal_lipoprotein_level | 1.19077876 |
| 88 | MP0002090_abnormal_vision | 1.16836902 |
| 89 | MP0000751_myopathy | 1.16074707 |
| 90 | MP0002723_abnormal_immune_serum | 1.15784305 |
| 91 | MP0005670_abnormal_white_adipose | 1.14290118 |
| 92 | MP0002452_abnormal_antigen_presenting | 1.14199768 |
| 93 | MP0001348_abnormal_lacrimal_gland | 1.13549088 |
| 94 | MP0005464_abnormal_platelet_physiology | 1.13491152 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 1.12261226 |
| 96 | MP0008874_decreased_physiological_sensi | 1.12255552 |
| 97 | MP0005666_abnormal_adipose_tissue | 1.09648280 |
| 98 | MP0000955_abnormal_spinal_cord | 1.09606314 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 1.09294170 |
| 100 | MP0004924_abnormal_behavior | 1.08985177 |
| 101 | MP0005386_behavior/neurological_phenoty | 1.08985177 |
| 102 | MP0010386_abnormal_urinary_bladder | 1.08979831 |
| 103 | MP0006072_abnormal_retinal_apoptosis | 1.07939358 |
| 104 | MP0009840_abnormal_foam_cell | 1.07688196 |
| 105 | MP0001845_abnormal_inflammatory_respons | 1.07575871 |
| 106 | MP0009764_decreased_sensitivity_to | 1.07247658 |
| 107 | MP0002184_abnormal_innervation | 1.07169711 |
| 108 | MP0005409_darkened_coat_color | 1.06945293 |
| 109 | MP0008469_abnormal_protein_level | 1.06610267 |
| 110 | MP0005023_abnormal_wound_healing | 1.06345997 |
| 111 | MP0002882_abnormal_neuron_morphology | 1.04984283 |
| 112 | MP0000013_abnormal_adipose_tissue | 1.04559217 |
| 113 | MP0001958_emphysema | 1.04166443 |
| 114 | MP0008872_abnormal_physiological_respon | 1.03809906 |
| 115 | MP0005332_abnormal_amino_acid | 1.03337793 |
| 116 | MP0003634_abnormal_glial_cell | 1.02543727 |
| 117 | MP0003045_fibrosis | 1.01517258 |
| 118 | MP0002229_neurodegeneration | 1.01069736 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 1.00895307 |
| 120 | MP0004019_abnormal_vitamin_homeostasis | 1.00818305 |
| 121 | MP0005310_abnormal_salivary_gland | 1.00610541 |
| 122 | MP0004185_abnormal_adipocyte_glucose | 1.00347772 |
| 123 | MP0005083_abnormal_biliary_tract | 0.99639907 |
| 124 | MP0004142_abnormal_muscle_tone | 0.98123727 |
| 125 | MP0005645_abnormal_hypothalamus_physiol | 0.97656937 |
| 126 | MP0001800_abnormal_humoral_immune | 0.97302739 |
| 127 | MP0001819_abnormal_immune_cell | 0.96722603 |
| 128 | MP0001853_heart_inflammation | 0.96248849 |
| 129 | MP0002420_abnormal_adaptive_immunity | 0.95614899 |
| 130 | MP0002557_abnormal_social/conspecific_i | 0.95430044 |
| 131 | MP0002254_reproductive_system_inflammat | 0.94945746 |
| 132 | MP0002796_impaired_skin_barrier | 0.94884869 |
| 133 | MP0005390_skeleton_phenotype | 0.94741245 |
| 134 | MP0005253_abnormal_eye_physiology | 0.94388379 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.94117267 |
| 136 | MP0002118_abnormal_lipid_homeostasis | 0.94013390 |
| 137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93961360 |
| 138 | MP0005365_abnormal_bile_salt | 0.92582924 |
| 139 | MP0005646_abnormal_pituitary_gland | 0.92022281 |
| 140 | MP0005397_hematopoietic_system_phenotyp | 0.91323108 |
| 141 | MP0001545_abnormal_hematopoietic_system | 0.91323108 |
| 142 | MP0002069_abnormal_eating/drinking_beha | 0.91227484 |
| 143 | MP0003183_abnormal_peptide_metabolism | 0.89936485 |
| 144 | MP0005166_decreased_susceptibility_to | 0.89867627 |
| 145 | MP0005671_abnormal_response_to | 0.89612710 |
| 146 | MP0002971_abnormal_brown_adipose | 0.88814951 |
| 147 | MP0000678_abnormal_parathyroid_gland | 0.87997136 |
| 148 | MP0002638_abnormal_pupillary_reflex | 0.87548391 |
| 149 | MP0003646_muscle_fatigue | 0.85671048 |
| 150 | MP0001765_abnormal_ion_homeostasis | 0.85472739 |
| 151 | MP0003283_abnormal_digestive_organ | 0.84438089 |
| 152 | MP0001984_abnormal_olfaction | 0.83993616 |
| 153 | MP0009278_abnormal_bone_marrow | 0.83373886 |
| 154 | MP0009333_abnormal_splenocyte_physiolog | 0.83117863 |
| 155 | MP0005448_abnormal_energy_balance | 0.82614801 |
| 156 | MP0003011_delayed_dark_adaptation | 0.82047570 |
| 157 | MP0005164_abnormal_response_to | 0.81462459 |
| 158 | MP0002896_abnormal_bone_mineralization | 0.81236531 |
| 159 | MP0006276_abnormal_autonomic_nervous | 0.81219172 |
| 160 | MP0005165_increased_susceptibility_to | 0.79524562 |
| 161 | MP0004147_increased_porphyrin_level | 0.78502059 |
| 162 | MP0002405_respiratory_system_inflammati | 0.77299696 |
| 163 | MP0002332_abnormal_exercise_endurance | 0.75072004 |
| 164 | MP0003828_pulmonary_edema | 0.74136363 |
| 165 | MP0005085_abnormal_gallbladder_physiolo | 0.73869454 |
| 166 | MP0000767_abnormal_smooth_muscle | 0.73399611 |
| 167 | MP0002876_abnormal_thyroid_physiology | 0.73358768 |
| 168 | MP0000778_abnormal_nervous_system | 0.72875111 |
| 169 | MP0001756_abnormal_urination | 0.72132175 |
| 170 | MP0002078_abnormal_glucose_homeostasis | 0.71621840 |
| 171 | MP0001542_abnormal_bone_strength | 0.71455579 |
| 172 | MP0003795_abnormal_bone_structure | 0.71270870 |
| 173 | MP0000681_abnormal_thyroid_gland | 0.69976862 |
| 174 | MP0008004_abnormal_stomach_pH | 0.69457963 |
| 175 | MP0004264_abnormal_extraembryonic_tissu | 0.67930087 |
| 176 | MP0000249_abnormal_blood_vessel | 0.67700925 |
| 177 | MP0001851_eye_inflammation | 0.67476314 |
| 178 | MP0005623_abnormal_meninges_morphology | 0.65420169 |
| 179 | MP0000747_muscle_weakness | 0.65380575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.25593146 |
| 2 | Focal motor seizures (HP:0011153) | 4.62742780 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.54333135 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.54333135 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.54333135 |
| 6 | Visual hallucinations (HP:0002367) | 3.82995057 |
| 7 | Focal seizures (HP:0007359) | 3.70964675 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 3.53315823 |
| 9 | Action tremor (HP:0002345) | 3.50637647 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.28168652 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.04025124 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.03168749 |
| 13 | Vertebral compression fractures (HP:0002953) | 3.01606500 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 2.95092933 |
| 15 | Febrile seizures (HP:0002373) | 2.91721366 |
| 16 | Abnormal eating behavior (HP:0100738) | 2.91621937 |
| 17 | Hypercortisolism (HP:0001578) | 2.91442049 |
| 18 | Atonic seizures (HP:0010819) | 2.89143141 |
| 19 | Depression (HP:0000716) | 2.88670835 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 2.86650880 |
| 21 | Dysostosis multiplex (HP:0000943) | 2.84905862 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 2.84777343 |
| 23 | Dysdiadochokinesis (HP:0002075) | 2.79994035 |
| 24 | Eczematoid dermatitis (HP:0000976) | 2.79322151 |
| 25 | Status epilepticus (HP:0002133) | 2.69109763 |
| 26 | Postural instability (HP:0002172) | 2.68952613 |
| 27 | Absence seizures (HP:0002121) | 2.67218154 |
| 28 | Increased circulating renin level (HP:0000848) | 2.64112849 |
| 29 | Nuclear cataract (HP:0100018) | 2.63013407 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61058417 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.61058417 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.58652979 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.58652979 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.58652979 |
| 35 | Annular pancreas (HP:0001734) | 2.53252562 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.52068484 |
| 37 | Cholecystitis (HP:0001082) | 2.52068484 |
| 38 | Cerebral aneurysm (HP:0004944) | 2.51590467 |
| 39 | Protrusio acetabuli (HP:0003179) | 2.50897232 |
| 40 | Anxiety (HP:0000739) | 2.49659886 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.47882606 |
| 42 | Torticollis (HP:0000473) | 2.47376267 |
| 43 | Hemiplegia (HP:0002301) | 2.47234333 |
| 44 | Obstructive sleep apnea (HP:0002870) | 2.45600563 |
| 45 | Thin bony cortex (HP:0002753) | 2.44124473 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.43906539 |
| 47 | Dialeptic seizures (HP:0011146) | 2.42203920 |
| 48 | J-shaped sella turcica (HP:0002680) | 2.40950835 |
| 49 | Central scotoma (HP:0000603) | 2.40201460 |
| 50 | Ankle clonus (HP:0011448) | 2.39249766 |
| 51 | Growth hormone excess (HP:0000845) | 2.38631410 |
| 52 | Amyloidosis (HP:0011034) | 2.37948234 |
| 53 | Abnormality of complement system (HP:0005339) | 2.37778491 |
| 54 | Hyperacusis (HP:0010780) | 2.36828581 |
| 55 | Pheochromocytoma (HP:0002666) | 2.36542468 |
| 56 | Apathy (HP:0000741) | 2.35899631 |
| 57 | Gout (HP:0001997) | 2.34940011 |
| 58 | Glomerulonephritis (HP:0000099) | 2.34702957 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.32660203 |
| 60 | Cervical subluxation (HP:0003308) | 2.32201359 |
| 61 | Intention tremor (HP:0002080) | 2.31944421 |
| 62 | Failure to thrive in infancy (HP:0001531) | 2.31664512 |
| 63 | Diminished motivation (HP:0000745) | 2.31657205 |
| 64 | Distal lower limb muscle weakness (HP:0009053) | 2.30121477 |
| 65 | Recurrent abscess formation (HP:0002722) | 2.29580025 |
| 66 | Achilles tendon contracture (HP:0001771) | 2.28350347 |
| 67 | Turricephaly (HP:0000262) | 2.28194543 |
| 68 | Global brain atrophy (HP:0002283) | 2.27781950 |
| 69 | Dysmetric saccades (HP:0000641) | 2.26061730 |
| 70 | Deep venous thrombosis (HP:0002625) | 2.25751905 |
| 71 | Premature rupture of membranes (HP:0001788) | 2.25201361 |
| 72 | Complement deficiency (HP:0004431) | 2.23749532 |
| 73 | Impaired social interactions (HP:0000735) | 2.23717619 |
| 74 | Abnormal social behavior (HP:0012433) | 2.23717619 |
| 75 | Dysmetria (HP:0001310) | 2.22773679 |
| 76 | Focal dystonia (HP:0004373) | 2.22167880 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 2.21994256 |
| 78 | Hyperparathyroidism (HP:0000843) | 2.21854444 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.21635626 |
| 80 | Orchitis (HP:0100796) | 2.18384009 |
| 81 | Adrenal overactivity (HP:0002717) | 2.18142161 |
| 82 | Purpura (HP:0000979) | 2.16987700 |
| 83 | Polyphagia (HP:0002591) | 2.16539636 |
| 84 | Recurrent bacterial skin infections (HP:0005406) | 2.16482785 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15156222 |
| 86 | Abnormality of the Achilles tendon (HP:0005109) | 2.13433063 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 2.12355796 |
| 88 | Craniofacial dystonia (HP:0012179) | 2.11582407 |
| 89 | Insomnia (HP:0100785) | 2.09741221 |
| 90 | Mutism (HP:0002300) | 2.08815913 |
| 91 | Oligomenorrhea (HP:0000876) | 2.08511507 |
| 92 | Ketoacidosis (HP:0001993) | 2.08263684 |
| 93 | Hypoventilation (HP:0002791) | 2.07746379 |
| 94 | Abnormality of binocular vision (HP:0011514) | 2.07594892 |
| 95 | Diplopia (HP:0000651) | 2.07594892 |
| 96 | Truncal ataxia (HP:0002078) | 2.07590608 |
| 97 | Congenital stationary night blindness (HP:0007642) | 2.06033482 |
| 98 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.04748851 |
| 99 | Exercise-induced myalgia (HP:0003738) | 2.03994868 |
| 100 | Hyperactive renin-angiotensin system (HP:0000841) | 2.03226710 |
| 101 | Hemiparesis (HP:0001269) | 2.02023840 |
| 102 | Sensorimotor neuropathy (HP:0007141) | 2.01751945 |
| 103 | Cholelithiasis (HP:0001081) | 2.01175720 |
| 104 | Poor eye contact (HP:0000817) | 2.00192733 |
| 105 | Myositis (HP:0100614) | 1.99111428 |
| 106 | Pathologic fracture (HP:0002756) | 1.98829244 |
| 107 | Genetic anticipation (HP:0003743) | 1.98034458 |
| 108 | Polycythemia (HP:0001901) | 1.97698889 |
| 109 | Neuroendocrine neoplasm (HP:0100634) | 1.97559496 |
| 110 | Bradykinesia (HP:0002067) | 1.97533274 |
| 111 | Bone pain (HP:0002653) | 1.97290833 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.96601677 |
| 113 | Distal upper limb amyotrophy (HP:0007149) | 1.96284191 |
| 114 | Upper limb amyotrophy (HP:0009129) | 1.96284191 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.95115727 |
| 116 | Cellulitis (HP:0100658) | 1.95073690 |
| 117 | Polygenic inheritance (HP:0010982) | 1.92471943 |
| 118 | Psychosis (HP:0000709) | 1.92434629 |
| 119 | Retinal atrophy (HP:0001105) | 1.91803708 |
| 120 | Flat acetabular roof (HP:0003180) | 1.91453323 |
| 121 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.90639226 |
| 122 | Myocardial infarction (HP:0001658) | 1.88862674 |
| 123 | Mediastinal lymphadenopathy (HP:0100721) | 1.88502013 |
| 124 | Increased serum ferritin (HP:0003281) | 1.88014669 |
| 125 | Ventricular fibrillation (HP:0001663) | 1.87433241 |
| 126 | Hand muscle atrophy (HP:0009130) | 1.86803623 |
| 127 | Amblyopia (HP:0000646) | 1.86303008 |
| 128 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.85983881 |
| 129 | Axonal loss (HP:0003447) | 1.84734195 |
| 130 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.84416785 |
| 131 | Broad face (HP:0000283) | 1.84192139 |
| 132 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84041521 |
| 133 | Gingivitis (HP:0000230) | 1.84015958 |
| 134 | Rigidity (HP:0002063) | 1.82816465 |
| 135 | Pigmentary retinal degeneration (HP:0001146) | 1.82528348 |
| 136 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82401719 |
| 137 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.81711064 |
| 138 | Ketosis (HP:0001946) | 1.81641784 |
| 139 | Dementia (HP:0000726) | 1.81538632 |
| 140 | Gaze-evoked nystagmus (HP:0000640) | 1.80271542 |
| 141 | Reticulocytosis (HP:0001923) | 1.80104182 |
| 142 | Abnormal gallbladder morphology (HP:0012437) | 1.79534021 |
| 143 | Progressive neurologic deterioration (HP:0002344) | 1.79470418 |
| 144 | Slow saccadic eye movements (HP:0000514) | 1.78173184 |
| 145 | Disinhibition (HP:0000734) | 1.77359752 |
| 146 | Increased connective tissue (HP:0009025) | 1.76689792 |
| 147 | Emphysema (HP:0002097) | 1.76073071 |
| 148 | Diaphragmatic weakness (HP:0009113) | 1.75821575 |
| 149 | Gastrointestinal stroma tumor (HP:0100723) | 1.75076042 |
| 150 | Abnormality of the thoracic spine (HP:0100711) | 1.75046788 |
| 151 | Agitation (HP:0000713) | 1.74112684 |
| 152 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73515571 |
| 153 | Abnormality of the nasal mucosa (HP:0000433) | 1.72872930 |
| 154 | Rapidly progressive (HP:0003678) | 1.72783407 |
| 155 | Upper motor neuron abnormality (HP:0002127) | 1.72489325 |
| 156 | Distal lower limb amyotrophy (HP:0008944) | 1.72225602 |
| 157 | Thoracic kyphosis (HP:0002942) | 1.70931671 |
| 158 | Aneurysm (HP:0002617) | 1.70191564 |
| 159 | Blue sclerae (HP:0000592) | 1.69717648 |
| 160 | Clumsiness (HP:0002312) | 1.69570641 |
| 161 | Loss of speech (HP:0002371) | 1.69556193 |
| 162 | Impaired smooth pursuit (HP:0007772) | 1.69528794 |
| 163 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.69130798 |
| 164 | Prolonged neonatal jaundice (HP:0006579) | 1.68964064 |
| 165 | Optic neuritis (HP:0100653) | 1.66224321 |
| 166 | Retrobulbar optic neuritis (HP:0100654) | 1.66224321 |
| 167 | Chronic obstructive pulmonary disease (HP:0006510) | 1.65751014 |
| 168 | Obstructive lung disease (HP:0006536) | 1.65751014 |
| 169 | Hypertriglyceridemia (HP:0002155) | 1.61802966 |
| 170 | Malnutrition (HP:0004395) | 1.60757027 |
| 171 | Increased variability in muscle fiber diameter (HP:0003557) | 1.60718788 |
| 172 | Nephritis (HP:0000123) | 1.58850713 |
| 173 | Bulbar palsy (HP:0001283) | 1.57757085 |
| 174 | Increased IgE level (HP:0003212) | 1.57563643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.31724444 |
| 2 | NTRK3 | 3.18845354 |
| 3 | IRAK3 | 3.13198512 |
| 4 | EPHA4 | 2.95294861 |
| 5 | TRIB3 | 2.28635487 |
| 6 | DAPK2 | 2.25779746 |
| 7 | KSR2 | 2.24115800 |
| 8 | PRKD3 | 2.13975413 |
| 9 | NME2 | 2.06953696 |
| 10 | PINK1 | 2.02245034 |
| 11 | SMG1 | 2.01636205 |
| 12 | TESK1 | 1.95668757 |
| 13 | PAK6 | 1.94149181 |
| 14 | MINK1 | 1.89219615 |
| 15 | NTRK1 | 1.88407412 |
| 16 | TAOK2 | 1.87773834 |
| 17 | ERN1 | 1.81203872 |
| 18 | CAMKK1 | 1.71090115 |
| 19 | ICK | 1.68461584 |
| 20 | STK38 | 1.62804125 |
| 21 | TBK1 | 1.57494800 |
| 22 | RIPK1 | 1.57071898 |
| 23 | MAP3K4 | 1.56590111 |
| 24 | MAP2K3 | 1.54596569 |
| 25 | RIPK4 | 1.54278796 |
| 26 | MAP3K3 | 1.45301718 |
| 27 | DAPK1 | 1.44661421 |
| 28 | MAP2K4 | 1.43080678 |
| 29 | PHKG1 | 1.39394550 |
| 30 | PHKG2 | 1.39394550 |
| 31 | ARAF | 1.38487174 |
| 32 | GRK5 | 1.37851581 |
| 33 | FGFR4 | 1.34992544 |
| 34 | NTRK2 | 1.34260244 |
| 35 | TYRO3 | 1.33833061 |
| 36 | MAP3K12 | 1.33417016 |
| 37 | DDR2 | 1.32738890 |
| 38 | LMTK2 | 1.29294542 |
| 39 | TYK2 | 1.29021043 |
| 40 | TESK2 | 1.24729514 |
| 41 | MAP3K14 | 1.24350760 |
| 42 | PRKCH | 1.23862523 |
| 43 | BMX | 1.23375306 |
| 44 | IRAK4 | 1.22693610 |
| 45 | FGR | 1.22149378 |
| 46 | BLK | 1.17470614 |
| 47 | CDK5 | 1.17388630 |
| 48 | SGK223 | 1.13734078 |
| 49 | SGK494 | 1.13734078 |
| 50 | TAOK1 | 1.13633053 |
| 51 | MAP3K13 | 1.12419840 |
| 52 | EEF2K | 1.12324698 |
| 53 | PRPF4B | 1.11565415 |
| 54 | EPHA2 | 1.10781473 |
| 55 | MAP4K1 | 1.10460799 |
| 56 | SIK2 | 1.06706670 |
| 57 | SGK3 | 1.06515316 |
| 58 | WNK4 | 1.04525644 |
| 59 | PIM2 | 1.03884243 |
| 60 | PTK2B | 1.03289843 |
| 61 | PDGFRA | 1.01709176 |
| 62 | RET | 1.01423374 |
| 63 | MAP2K7 | 1.00333658 |
| 64 | SIK3 | 0.99939322 |
| 65 | MAP3K11 | 0.99593721 |
| 66 | MAP3K6 | 0.99012591 |
| 67 | CAMKK2 | 0.98184376 |
| 68 | PTK2 | 0.97815834 |
| 69 | MAP3K2 | 0.96968359 |
| 70 | UHMK1 | 0.96774924 |
| 71 | MARK1 | 0.96616630 |
| 72 | TNK2 | 0.95582284 |
| 73 | ZAP70 | 0.95426061 |
| 74 | MAP3K1 | 0.95235761 |
| 75 | PAK4 | 0.92939162 |
| 76 | MOS | 0.92659290 |
| 77 | SIK1 | 0.89976402 |
| 78 | CDK12 | 0.87920398 |
| 79 | PTK6 | 0.87229395 |
| 80 | MATK | 0.87206911 |
| 81 | CAMK1G | 0.86194065 |
| 82 | PDPK1 | 0.85652777 |
| 83 | PRKCG | 0.84052495 |
| 84 | IRAK2 | 0.83895117 |
| 85 | PRKD2 | 0.83534898 |
| 86 | RPS6KA2 | 0.82833134 |
| 87 | FES | 0.82293532 |
| 88 | TGFBR2 | 0.80794956 |
| 89 | JAK3 | 0.80371564 |
| 90 | SGK2 | 0.80335458 |
| 91 | TTN | 0.79255519 |
| 92 | KSR1 | 0.78085111 |
| 93 | CAMK1 | 0.77687251 |
| 94 | PDK1 | 0.76397739 |
| 95 | GRK6 | 0.72826654 |
| 96 | JAK1 | 0.71450765 |
| 97 | MAP3K7 | 0.71238625 |
| 98 | CAMK1D | 0.68799404 |
| 99 | NEK1 | 0.68267234 |
| 100 | SGK1 | 0.67706208 |
| 101 | MAP2K1 | 0.66967223 |
| 102 | PRKCZ | 0.66286650 |
| 103 | WNK3 | 0.65702918 |
| 104 | MAPK15 | 0.64813726 |
| 105 | MAPKAPK3 | 0.64015041 |
| 106 | CAMK2A | 0.63960861 |
| 107 | IKBKE | 0.63924171 |
| 108 | CDC42BPA | 0.63310984 |
| 109 | MTOR | 0.63028794 |
| 110 | ABL2 | 0.62520851 |
| 111 | PRKAA1 | 0.62514529 |
| 112 | PRKG2 | 0.60203773 |
| 113 | HIPK2 | 0.57794605 |
| 114 | CSK | 0.57116662 |
| 115 | PKN2 | 0.56532252 |
| 116 | WNK1 | 0.56449940 |
| 117 | MAP2K2 | 0.56163756 |
| 118 | BRAF | 0.56022835 |
| 119 | ALK | 0.55963090 |
| 120 | MARK2 | 0.55811124 |
| 121 | GRK7 | 0.55307554 |
| 122 | OXSR1 | 0.54594875 |
| 123 | STK11 | 0.54363504 |
| 124 | CDK15 | 0.54231149 |
| 125 | CDK18 | 0.53871400 |
| 126 | CDK14 | 0.53437506 |
| 127 | RPS6KC1 | 0.52205065 |
| 128 | RPS6KL1 | 0.52205065 |
| 129 | FER | 0.51950848 |
| 130 | DYRK1B | 0.51861695 |
| 131 | JAK2 | 0.51714092 |
| 132 | MAPK13 | 0.50875239 |
| 133 | MAPK12 | 0.50820019 |
| 134 | CAMK4 | 0.50327281 |
| 135 | CHUK | 0.50248589 |
| 136 | MAPK11 | 0.50157695 |
| 137 | LIMK1 | 0.49762085 |
| 138 | CSF1R | 0.49634111 |
| 139 | PAK3 | 0.49476700 |
| 140 | PRKACG | 0.48900413 |
| 141 | IKBKB | 0.48298917 |
| 142 | CAMK2G | 0.47823053 |
| 143 | LATS2 | 0.47736889 |
| 144 | LRRK2 | 0.47129011 |
| 145 | EPHB1 | 0.46766754 |
| 146 | CDK11A | 0.46381647 |
| 147 | RPS6KA3 | 0.45135525 |
| 148 | SCYL2 | 0.42039339 |
| 149 | MAPK4 | 0.39398761 |
| 150 | MST1R | 0.38484454 |
| 151 | MAPK7 | 0.38075446 |
| 152 | PDGFRB | 0.37554462 |
| 153 | HCK | 0.35342929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.94886383 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94066309 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.52313704 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.26550868 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23924053 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.14868665 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.05248847 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01913929 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 1.95466939 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.93522574 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89867046 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.76923718 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71279335 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.67812245 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.67701557 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.61366744 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59272485 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.57041817 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.56448940 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.52708545 |
| 21 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50192392 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49963972 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.49427352 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.47846374 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.46153899 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.45527724 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44428767 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.44105023 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40222233 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37201104 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.33904424 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33347515 |
| 33 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.33304268 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.33140904 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.33090771 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.33087032 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30095992 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.25818780 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22945387 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.22939785 |
| 41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21755876 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.21350000 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.17735702 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 1.16550506 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16049039 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.15470255 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14841825 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13370719 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12496844 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.12051350 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09596828 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.09152554 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 1.07956354 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06440175 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06400533 |
| 56 | Cocaine addiction_Homo sapiens_hsa05030 | 1.05152888 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04820266 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 1.02804227 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01550515 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00083768 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97769611 |
| 62 | Long-term depression_Homo sapiens_hsa04730 | 0.95819637 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.95748799 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94914369 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94373853 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92767142 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92638637 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92636210 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92487519 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92240973 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90884184 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89857607 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89697035 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.89149687 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88789359 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88262332 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87528084 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.87222495 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 0.87164610 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.87028474 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86632183 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85937005 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85411541 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.85064765 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85028117 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83886046 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.83276576 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82484401 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81180710 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.80266462 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79593036 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78762844 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.78316959 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77550478 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77126625 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76896926 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76656224 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76634714 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.73288484 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71387345 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71295154 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70996960 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69173795 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68971151 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68519853 |
| 106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68114938 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68011214 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67427630 |
| 109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67233682 |
| 110 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67194289 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67099808 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66818605 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66378889 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65530360 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65402879 |
| 116 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.65353932 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65223981 |
| 118 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64955810 |
| 119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64114472 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63714793 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62355175 |
| 122 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62354725 |
| 123 | Measles_Homo sapiens_hsa05162 | 0.62206655 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61336354 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61267945 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60998916 |
| 127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60971407 |
| 128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60699422 |
| 129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60336236 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60145165 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59390015 |
| 132 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59155194 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58688337 |
| 134 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58217567 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57082487 |
| 136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56660279 |
| 137 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54675454 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.54580040 |
| 139 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54437846 |
| 140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54278926 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54058904 |
| 142 | Focal adhesion_Homo sapiens_hsa04510 | 0.53172956 |
| 143 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52037957 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.51855981 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51617308 |
| 146 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51417583 |
| 147 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.50515283 |
| 148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50202586 |
| 149 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49659072 |
| 150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49547036 |
| 151 | Asthma_Homo sapiens_hsa05310 | 0.48243975 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47930248 |
| 153 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46895150 |
| 154 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46867150 |
| 155 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46093461 |
| 156 | ABC transporters_Homo sapiens_hsa02010 | 0.46045071 |
| 157 | Insulin resistance_Homo sapiens_hsa04931 | 0.46008659 |
| 158 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45438767 |
| 159 | Bladder cancer_Homo sapiens_hsa05219 | 0.45185324 |
| 160 | Prion diseases_Homo sapiens_hsa05020 | 0.44789172 |
| 161 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42133223 |
| 162 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42033167 |

